Armata Pharmaceuticals Inc

Research Armata Pharmaceuticals Inc (ARMP) on Bullrun: market cap USD 237.15M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerARMP
• ExchangeNYSE MKT
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 237.15M
• Financial periodFY2025
• Net income-USD 173.80M
• Free cash flow-USD 26.31M

Valuation Snapshot

latest market cap is USD 237.15M.

About Armata Pharmaceuticals Inc

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA03 for Pseudomonas aeruginosa . The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc.

Frequently asked questions

What is Armata Pharmaceuticals Inc's market cap?

Armata Pharmaceuticals Inc's market capitalization is USD 237.15M.

What does Armata Pharmaceuticals Inc do?

Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology.